IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells

被引:60
作者
Zou, Minghua [1 ]
Zhang, Xianquan [1 ]
Xu, Changhua [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Oncol, 74 Linjiang Rd, Chongqing 400010, Peoples R China
关键词
3; '-Diindolylmethane; ovarian cancer; STAT3; metastasis; IL6; MMP; HUMAN BREAST-CANCER; NF-KAPPA-B; GENE-EXPRESSION; PROSTATE-CANCER; IN-VITRO; INTERLEUKIN-6; STAT3; IL-6; INDOLE-3-CARBINOL; ACTIVATION;
D O I
10.1007/s13402-015-0251-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Ovarian cancer is a highly lethal gynecological malignancy for which the overall prognosis has remained poor over the past few decades. Interleukin (IL6) has been found to be a major contributor to the initiation and progression of ovarian cancer. This cytokine exerts its activity through activation of several signaling pathways, in particular the signal transducer and activator of transcription (STAT3) pathway. Here, we aimed at investigating the capacity of a natural dietary compound found in cruciferous vegetables, i.e., 3,3'-diindolylmethane (DIM), to target the metastatic phenotype of ovarian cancer cells through functional p-STAT3. Methods The human ovarian carcinoma-derived cell lines SKOV3 and A2780 were treated with IL6 and/or DIM and subjected to in vitro proliferation, adhesion, migration and invasion assays to assess the anti-metastatic and anti-IL6 effects of DIM, as well as to assess gene expression alterations before and after shRNA-mediated STAT3 silencing. Results We found that DIM inhibits IL6-mediated increases in ovarian cancer cell adhesion, migration and invasion. These results were corroborated by shRNA-mediated STAT3 silencing. Through Western blot and ELISA analyses direct evidence was provided for the capacity of DIM to inhibit ovarian cancer cell adhesion, migration and invasion, which was found to be associated with down-regulation of the matrix metalloproteinases MMP-2 and MMP-9. Conclusions From our data we conclude that DIM exhibits an anti-IL6-like activity by inhibiting p-STAT3 enhanced ovarian cancer cell proliferation and in vitro metastasis-associated events, i.e., adhesion, migration and invasion. Most significantly, MMP-2 and MMP-9, which are known to promote and enhance metastasis, were found to act as targets of DIM. This anti-IL6-like property of DIM may pave the way for the development of novel ovarian cancer preventive and/or therapeutic strategies.
引用
收藏
页码:47 / 57
页数:11
相关论文
共 44 条
[31]   The role of constitutively active signal transducer and activator of transcription 3 in ovarian turnorigenesis and prognosis [J].
Rosen, Daniel G. ;
Mercado-Uribe, Imelda ;
Yang, Gong ;
Bast, Robert C., Jr. ;
Amin, Hesham M. ;
Lai, Raymond ;
Liu, Jinsong .
CANCER, 2006, 107 (11) :2730-2740
[32]   Circulating interleukin-6 predicts survival in patients with metastatic breast cancer [J].
Salgado, R ;
Junius, S ;
Benoy, I ;
Van Dam, P ;
Vermeulen, P ;
Van Marck, E ;
Huget, P ;
Dirix, LY .
INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (05) :642-646
[33]   HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression [J].
Shah, Nilay ;
Jin, Kideok ;
Cruz, Leigh-Ann ;
Park, Sunju ;
Sadik, Helen ;
Cho, Soonweng ;
Goswami, Chirayu Pankaj ;
Nakshatri, Harikrishna ;
Gupta, Rajnish ;
Chang, Howard Y. ;
Zhang, Zhe ;
Cimino-Mathews, Ashley ;
Cope, Leslie ;
Umbricht, Christopher ;
Sukumar, Saraswati .
CANCER RESEARCH, 2013, 73 (17) :5449-5458
[34]   Cancer Statistics, 2014 [J].
Siegel, Rebecca ;
Ma, Jiemin ;
Zou, Zhaohui ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (01) :9-29
[35]   Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer [J].
Songür, N ;
Kuru, B ;
Kalkan, F ;
Özdilekcan, C ;
Çakmak, H ;
Hizel, N .
TUMORI JOURNAL, 2004, 90 (02) :196-200
[36]   Activated STAT3 as a correlate of distant metastasis in prostate cancer: A secondary analysis of radiation therapy oncology group 86-10 [J].
Torres-Roca, Javier F. ;
DeSilvio, Michelle ;
Mora, Linda B. ;
Khor, Li Yan ;
Hammond, Elizabeth ;
Ahmad, Nazeel ;
Jove, Richard ;
Forman, Jeffrey ;
Lee, R. Jeffrey ;
Sandier, Howard ;
Pollack, Alan .
UROLOGY, 2007, 69 (03) :505-509
[37]   STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma [J].
Tu, Bing ;
Du, Lin ;
Fan, Qi-Ming ;
Tang, Ze ;
Tang, Ting-Ting .
CANCER LETTERS, 2012, 325 (01) :80-88
[38]   Rethinking ovarian cancer: recommendations for improving outcomes [J].
Vaughan, Sebastian ;
Coward, Jermaine I. ;
Bast, Robert C., Jr. ;
Berchuck, Andy ;
Berek, Jonathan S. ;
Brenton, James D. ;
Coukos, George ;
Crum, Christopher C. ;
Drapkin, Ronny ;
Etemadmoghadam, Dariush ;
Friedlander, Michael ;
Gabra, Hani ;
Kaye, Stan B. ;
Lord, Chris J. ;
Lengyel, Ernst ;
Levine, Douglas A. ;
McNeish, Iain A. ;
Menon, Usha ;
Mills, Gordon B. ;
Nephew, Kenneth P. ;
Oza, Amit M. ;
Sood, Anil K. ;
Stronach, Euan A. ;
Walczak, Henning ;
Bowtell, David D. ;
Balkwill, Frances R. .
NATURE REVIEWS CANCER, 2011, 11 (10) :719-725
[39]   Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells [J].
Walter, M. ;
Liang, S. ;
Ghosh, S. ;
Hornsby, P. J. ;
Li, R. .
ONCOGENE, 2009, 28 (30) :2745-2755
[40]   Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells [J].
Wang, Yue ;
Li, Lingzhi ;
Guo, Xiaoqin ;
Jin, Xin ;
Sun, Weijia ;
Zhang, Xiaolei ;
Xu, Rui Cheng .
CYTOKINE, 2012, 59 (02) :228-236